National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 1428704

Government Disclaimer on use of this data

History of Changes from the VAERS Wayback Machine

First Appeared on 7/2/2021

VAERS ID: 1428704
VAERS Form:2
Age:
Sex:Female
Location:Foreign
Vaccinated:2021-04-26
Onset:2021-05-01
Submitted:0000-00-00
Entered:2021-06-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ET6956 / 2 LA / OT

Administered by: Other      Purchased by: ??
Symptoms: Vaccination failure, COVID-19, SARS-CoV-2 test, COVID-19 pneumonia

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died:2021-05-16
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Chronic lymphocytic leukaemia (cytostatic treatments); COVID-19; COVID-19 pneumonia; GERD; Hypertension
Allergies:
Diagnostic Lab Data: Test Date: 202105; Test Name: COVID-19 antigen test; Test Result: Positive
CDC 'Split Type': HUPFIZER INC2021730992

Write-up: COVID-19; Vaccination failure; COVID-19 pneumonia; This is a spontaneous report from a contactable physician downloaded from the Regulatory Authority-WEB. Regulatory authority number HU-OGYI-415121. A 79-years-old female patient received bnt162b2 (COMIRNATY, solution for injection, Lot Number: ET6956), via intramuscular route in the left arm on 26Apr2021 as DOSE 2, 0.3 ML, single dose for covid-19 immunization and first dose of bnt162b2 (COMIRNATY, solution for injection, Lot Number: EZ3620), via on an unspecified route of administration on 22Mar2021 as DOSE 1, single for covid-19 immunization. The patient''s medical history included hypertension, covid-19 pneumonia, chronic lymphocytic leukaemia in Feb2003 and received cytostatic treatments, covid-19 and gastrooesophageal reflux disease. The patient''s concomitant medications were not reported. The patient was hospitalized on 04May2021 after experiencing Covid-19 symptoms. Antigen test was positive. The patient received covid therapy, but her respiratory insufficiency progressed and was transferred to the Intensive Care Unit on 09May2021. Despite therapy, permanent improvement of the patients condition could not be reached. The patient passed away on 16May2021 at 18:49 due to Covid-19 pneumonia and ARDS. Sender Comment: The patient got infected with Covid-19 approximately 1 week after the second dose, therefore vaccination failure is considered possible. The case is serious because the outcome was fatal. Further information is not expected. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: ARDS; COVID-19

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=1428704&WAYBACKHISTORY=ON


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166